Skip to main content
. 2022 Dec 19;67(2):117–123. doi: 10.1002/mus.27761

TABLE 3.

Summary of side effects according to severity in all patients and after excluding those who needed IC by proxy

Category All patients, n (%) Excluding those who needed IC by proxy a , n (%)
Any reaction after either dose 138 (80.7%) 109 (82.6%)
First dose (N = 171) (N = 132)
All 104 (60.8%) 85 (64.4%)
Grade 1 79 (46.2%) 69 (52.3%)
Grade 2 20 (11.7%) 13 (9.8%)
Grade ≥3 2 (1.2%) 2 (1.5%)
Fever (>38.5°C) 3 (1.8%) 2 (1.5%)
Second dose (N = 170) (N = 132)
All 115 (67.6%) 93 (70.5%)
Grade 1 83 (48.8%) 71 (53.8%)
Grade 2 27 (15.9%) 20 (15.2%)
Grade ≥3 3 (1.8%) 2 (1.5%)
Fever (>38.5°C) 5 (2.9%) 2 (1.5%)
a

Severity was defined according to the Common Terminology Criteria for Adverse Events version 5.0.

Abbreviation: IC, informed consent (parents or siblings).